RedHill Biopharma Ltd., a specialty biopharmaceutical company, has entered into an exclusive worldwide development and commercialization licensing agreement, excluding North America, with Hyloris ...

Solventum’s Purification & Filtration business is highly complementary to Thermo Fisher’s bioproduction business. Solventum’s ...

Geographic expansion and regulatory expertise: With an increasingly complex global regulatory environment, biopharma ...

Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

The application was based on results from the three-arm Phase 3 CheckMate -8HW study.

Kineticos Life Sciences has launched Kinvard Bio Inc., a new anti-infectives biotech company based on research that has been ...

Maravai LifeSciences Inc., a provider of life science reagents and services to researchers and biotech innovators, has ...

AstraZeneca 4Q Revenues: $14.9 billion (+24%) 4Q Earnings: $1.5 billion (+56%) FY Revenues: $54.1 billion (+18%) FY Earnings: $7.0 billion (+18%) Comments: Oncology sales were $22.4 billion, up 21%.

Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...

Agreement allows Andelyn to use Stanton Lab CNS capsids to perform R&D services for clients developing gene therapies.